title: Epigenetic deregulation in myeloid malignancies.
abstract: Abnormal epigenetic patterning commonly is observed in cancer, including the myeloid malignancies acute myeloid leukemia and myelodysplastic syndromes. However, despite the universal nature of epigenetic deregulation, specific subtypes of myeloid disorders are associated with distinct epigenetic profiles, which accurately reflect the biologic heterogeneity of these disorders. In addition, mutations and genetic alterations of epigenetic-modifying enzymes frequently have been reported in these myeloid malignancies, emphasizing the importance of epigenetic deregulation in the initiation, progression, and outcome of these disorders. These aberrant epigenetic modifiers have become new targets for drug design, because their inhibition can potentially reverse the altered epigenetic landscapes that contribute to the development of the leukemia. In this review, we provide an overview of the role of epigenetic deregulation in leukemic transformation and their potential for therapeutic targeting.
authors.affiliation: Department of Pathology, University of Michigan Medical School, Ann Arbor, Mich.
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Meldi
authors.affiliation: Department of Pathology, University of Michigan Medical School, Ann Arbor, Mich. Electronic address: marfigue@med.umich.edu.
authors.forename: Maria E
authors.initials: ME
authors.lastname: Figueroa
mesh_terms: D000818:Animals; D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D044127:Epigenesis, Genetic / Q000187:drug effects; D006657:Histones / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D057170:Translational Research, Biomedical
chemical_list: D004791:Enzyme Inhibitors; D006657:Histones; D015254:DNA Modification Methylases